drugset / Trial / NCT05250947
Study Evaluating the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to assess the safety of using the Angel Concentrated Platelet Rich Plasma System to process Platelet Rich Plasma (PRP) to treat arthritis of the low back (lumbar spondylosis).
Timeline
- Start
- 2023-01-05
- Primary completion
- 2024-05-20
- Completion
- 2024-05-20
Outcome
Outcome not reported
Stopped (Business): “Projected cost to continue was not supported by the study budget and additional funds could not be obtained so the decision to close the study was made.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | 6 ml | Other |